MAR 01, 2021 8:24 AM PST

New Therapeutic Potential for a 'Miracle Poison'

WRITTEN BY: Carmen Leitch

Most people know botulism as a terrible disease and botox as a wrinkle reducer that can give people a 'frozen' appearance if it's used to excess. But these things are all made possible by the same 'miracle' toxin: botulinum, which is produced by the bacterium Clostridium botulinum and related species. The toxin has medicinal applications if it's used in the right dose. It doesn't only restore a youthful appearance, it can also treat chronic migraines, some chronic muscle spasms, and uncontrolled blinking.

 Public Domain CC0 Image

Reporting in Science, researchers have now reported a way to modify the botulinum toxin to open up more therapeutic applications. They were able to engineer the toxin protein to create unique, highly selective proteases, which are enzymes that can make cuts in other proteins that may activate or degrade those proteins. These modified proteases could be useful in the treatment of inflammation, aid in the growth of new neurons, or control growth hormone levels, for example, with many other potential applications.

"In theory, there is a really high ceiling for the number and type of conditions where you could intervene," said first study author Travis Blum, a postdoctoral researcher in the Department of Chemistry and Chemical Biology.

The research team was able to reprogram proteases so they could cut different targets in specific proteins, even when these proteins bore little or no similarity to the original protease target, and without cross-reactivity. They also began to find ways to create therapeutics that could be sent to the inside of a cell, what Blum called a "classical challenge in biology." Large amounts of botulinum toxin can move into neurons, making them even more useful.

It's now possible to make unique proteases directed at specific proteins. "Such a capability could make editing the proteome feasible in ways that complement the recent development of technologies to edit the genome," suggested David Liu, the Thomas Dudley Cabot Professor of the Natural Sciences, a Howard Hughes Medical Institute Investigator, and a core faculty member of the Broad Institute.

Proteins or proteases could act as therapeutics in various ways, such as modifying other proteins to trigger a downstream effect, or to eliminate other destructive or defective proteins, for example.

"Despite these important features, proteases have not been widely adopted as human therapeutics," said Liu, "primarily because of the lack of a technology to generate proteases that cleave protein targets of our choosing."

Liu's lab developed PACE (phage-assisted continuous evolution), which generates novel proteins without needing much maintenance from people. PACE is a system in which the evolution of a desired protein can be driven or directed by the continuous infection of a bacteria over generations by a bacteriophage, which induces changes in the bacterial genome (and hence, the proteins it makes). The scientists were able to use PACE to make so-called 'promiscuous' proteases more selective about which proteins they cut. Next, they engineered a protease that would identify an entirely new target.

"At the outset, we didn't know if it was even feasible to take this unique class of proteases and evolve them or teach them to cleave something new because that had never been done before," said Blum. But it worked.

They've made four proteases from three botulinum toxin families; all four stopped acting on their original targets and began specifically cutting new targets, all while maintaining the ability to get into cells. "You end up with a powerful tool to do intracellular therapy," said Blum.

Blum cautions that this work is still theoretical, because these proteases are not ready for use in the clinic; far from it. These new proteases might stimulate an immune response, for one thing. The team is now working to learn more about whether they can use other proteins that are less likely to trigger an immune attack as their starting material. They are also continuing to improve the botulinum toxin proteases.

"We're still trying to understand the system's limitations, but in an ideal world, we can think about using these toxins to theoretically cleave any protein of interest," said Blum.

Sources: AAAS/Eurekalert! via Harvard University, Science

About the Author
  • Experienced research scientist and technical expert with authorships on over 30 peer-reviewed publications, traveler to over 70 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
JAN 14, 2021
Microbiology
Decontaminating the Cancer Microbiome
JAN 14, 2021
Decontaminating the Cancer Microbiome
Valid scientific conclusions require a solid foundation of good data that comes from reliable techniques. Studies that i ...
JAN 24, 2021
Neuroscience
Is Parkinson's Disease Linked to Gut Fungi?
JAN 24, 2021
Is Parkinson's Disease Linked to Gut Fungi?
Studies show an association between the gut microbiome and Parkinson's disease. Up until now, though, no studies had ...
MAR 10, 2021
Clinical & Molecular DX
What's Your Type? Skin Microbes Linked to Dermatitis Severity.
MAR 10, 2021
What's Your Type? Skin Microbes Linked to Dermatitis Severity.
Microbiologists have discovered that the types of bacteria on a dermatitis patient’s skin affect the severity of t ...
MAR 25, 2021
Clinical & Molecular DX
Police Speeding Radar Technology Used to Catch Antibiotic-Resistant Bacteria
MAR 25, 2021
Police Speeding Radar Technology Used to Catch Antibiotic-Resistant Bacteria
Doppler radars are used by cops to catch speeding drivers, in spacecraft navigation, and for forecasting the weather. No ...
APR 02, 2021
Drug Discovery & Development
Anti-Parasitic Medication Could Be Therapy for COVID19
APR 02, 2021
Anti-Parasitic Medication Could Be Therapy for COVID19
What are tropical and neglected diseases? Chronic infections that plague developing nations with often little financial ...
APR 12, 2021
Cell & Molecular Biology
Deep Subsurface Microbes Are "Living Fossils"
APR 12, 2021
Deep Subsurface Microbes Are "Living Fossils"
Researchers were shocked when they saw the results of a genetic analysis comparing various microbes from around the worl ...
Loading Comments...